Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.

MLA

Gutiérrez, José María, et al. “Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.” Toxins, vol. 9, no. 5, May 2017. EBSCOhost, https://doi.org/10.3390/toxins9050163.

APA

Gutiérrez, J. M., Solano, G., Pla, D., Herrera, M., Segura, Á., Vargas, M., Villalta, M., Sánchez, A., Sanz, L., Lomonte, B., León, G., & Calvete, J. J. (2017). Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead. Toxins, 9(5). https://doi.org/10.3390/toxins9050163

Chicago

Gutiérrez, José María, Gabriela Solano, Davinia Pla, María Herrera, Álvaro Segura, Mariángela Vargas, Mauren Villalta, et al. 2017. “Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.” Toxins 9 (5). doi:10.3390/toxins9050163.